This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Title: Testing for COVID19 in low resource settings: what is need and how can we ensure equitable access?
Title: Serology testing of antigen and antibody for SARS-CoV-2
Title: Serology testing of antigen and antibody for SARS-CoV-2
Title: “Phase III clinical trail on CD24Fc as a non-antiviral immunomodulator in severe COVID-19 treatmentâ€
Title: Echinacea - A viable antiviral for treatment and prevention of COVID-19
Title: Growth of COVID-19 in the World using Machine Learning Approach
Title: “CD147 Receptor as a Target for SARS-CoV-2 Treatment: Analysis of the drugs Azithromycin, Indomethacin and Humanized Anti-CD147 Antibodyâ€
Title: Diacerein: A potential multi-target therapeutic drug for COVID-19
Title: COVID-19 Innate Immunity: The Neglected Step Syster
Title: Generation of human bronchial organoids for COVID-19 Research
Title: Early Stage Prediction of US County Vulnerability to the COVID-19 Pandemic
Title: Zinc as nutritional intervention and prevention measure for COVID-19 disease
Title: INSIGHT: A Scalable Isothermal NASBA-based Platform for COVID-19 Diagnosis
Title: INSIGHT: A Scalable Isothermal NASBA-based Platform for COVID-19 Diagnosis